A new bioproduction route for a novel antimicrobial peptide

Biotechnology and Bioengineering

Volumn 108, Issue 3, 2011, Pages 572-581

  Tay, Derrick Kok Sing ^a   Rajagopalan, Gobinath ^a   Li, Xiang ^a   Chen, Yu ^a   Lua, Linda H L ^b   Leong, Susanna Su Jan ^a  

^a Nanyang Technological University   (Singapore)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antimicrobial activity; Antimicrobial peptide; Bioprocess; E. coli; Human defensin 28

Indexed keywords

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL PEPTIDE; BIOPROCESSES; DEFENSINS; E. COLI;

AMINO ACIDS; CIRCULAR DICHROISM SPECTROSCOPY; DICHROISM; ESCHERICHIA COLI; PATHOGENS; PEPTIDES; POLYPEPTIDES; SYNTHESIS (CHEMICAL);

MICROORGANISMS;

BETA DEFENSIN; BETA DEFENSIN 28; HYBRID PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ALPHA HELIX; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BETA SHEET; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; MOLECULAR CLONING; NONHUMAN; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE;

ANTI-INFECTIVE AGENTS; BETA-DEFENSINS; BIOTECHNOLOGY; CIRCULAR DICHROISM; ESCHERICHIA COLI K12; HUMANS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS;

ESCHERICHIA COLI;

EID: 78751488915     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22970     Document Type: Article

References (35)

1. Brogden KA. 2005. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria. Nat Rev Microbiol 3: 238-250.
2. Bulet P, Stöcklin R, Menin L. 2004. Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev 198: 169-184.
3. Cabrita LD, Gilis D, Robertson AL, Dehouck Y, Rooman M, Bottomley SP. 2007. Enhancing the stability and solubility of TEV protease using in silico design. Prot Sci 16: 2360-2367.
4. Dosselli R, Gobbo M, Campestrini EBS, Reddi E. 2010. Porphyrin-Apidaecin conjugate as a new broad spectrum antibacterial agent. ACS Med Chem Lett 1(1): 35-38.
5. Elbing K, Brent R. 2002. Growth in liquid media. Current protocols in molecular biology, Unit 1.2.1., New York: John Wiley & Sons, Inc.
6. Fink AL, Calciano LJ, Goto Y, Kurotsu T, Palleros DR. 1994. Classification of acid denaturation of proteins: Intermediates and unfolded states. Biochemistry 33: 12504-12511.
7. Gast K, Zirwer D, Müller-Frohne M, Damaschun G. 1999. Trifluoroethanol-induced conformational transitions of proteins: Insights gained from the differences between a-lactalbumin and ribonuclease A. Protein Sci 8: 625-634.
8. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. 2003. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31: 3784-3788.
9. Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes S, Terán L. 2010. Antimicrobial peptides: General overview and clinical implications in human health and disease. Clin Immunol 135: 1-11.
10. Huang L, Ching CB, Jiang R, Leong SSJ. 2008. Production of bioactive human beta-defensin 5 and 6 in Escherichia coli by soluble fusion expression. Prot Expr Purif 61: 168-174.
11. Huang L, Leong SSJ, Jiang R. 2009. Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27 Appl. Microbiol Biotechnol 84(2): 301-308.
12. Humphrey JM, Chamberlin AR. 1997. Chemical synthesis of natural product peptides: Coupling methods for the incorporation of noncoded amino acids into peptides. Chem Rev 97(6): 2243-2266.
13. Kaar W, Hartmann BM, Y. Fan BZ, Lua LHL, Dexter AF, Falconer RJ, Middelberg APJ. 2009. Microbial bio-production of a recombinant stimuli-responsive biosurfactant. Biotechnol Bioeng 102(1): 176-187.
14. Kapust RB, Tözsér J, Copeland TD, Waugh DS. 2002. The P1' specificity of tobacco etch virus protease. Biochem Biophys Res Commun 294(5): 949-955.
15. Kinsella J. 1979. Functional properties of soy proteins. J Am Oil Chem Soc 56: 242-258.
16. Lehrer RI, Ganz T. 1999. Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11: 23-27.
17. Liu S, Zhou L, Li J, Suresh A, Verma C, Foo YH, Yap EPH, Tan DTH, Beuerman RW. 2008. Linear analogues of human b-Defensin 3: Concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells. ChemBioChem 9: 964-973.
18. Nominé Y, Ristriani T, Laurent C, Lefèvre J-F, Weiss É, Travé G. 2001. A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein. Protein Eng 14: 297-305.
19. Pazgiera M, Hoover DM, Yang D, Lu W, Lubkowski J. 2006. Human β-defensins. Cell Mol Life Sci 63: 1294-1313.
20. Poschner BC, Reed J, Langosch D, Hofmann MW. 2007. An automated application for deconvolution of circular dichroism spectra of small peptides. Anal Biochem 363(2): 306-308.
21. Roccatano D, Colombo G, Fioroni M, Mark AE. 2002. Mechanism by which 2, 2, 2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: A molecular dynamics study. Proc Natl Acad Sci USA 99(19): 12179-12184.
22. Rodríguez-Jiménez F, Krause A, Schulz S, Forssmann W, Conejo-Garcia J, Schreeb R, Motzkus D. 2003. Distribution of new human beta-defensin genes clustered on chromosome 20 in functionally different segments of epididymis. Genomics 81: 175-183.
23. Salt DJ, Leslie RB, Lillford PJ, Dmlnill P. 1982. Factors influencing protein structure during acid precipitation: A study of soya proteins. Eur J Appl Microbiol Biotechnol 14: 144-148.
24. Sambrook J, Russell DW. 2001. Preparation and transformation of competent E. coli using calciunl chloride. Molecular cloning: A laboratory manual, 3rd edition. New York: Cold Spring Harbor Laboratory Press.
25. Schulz A, Klüver E, Schulz-Maronde S, Adermann K. 2005. Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: Differences in disulfide formation and biological activity among human beta-defensins. Biopolymers 80: 34-49.
26. Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, Paul B, McCray J. 2002. Discovery of five conserved β-defensin gene clusters using a computational search strategy. PNAS 99(4): 2129-2133.
27. Stemp MJ, Guha S, Hartl FU, Barral JM. 2005. Efficient production of native actin upon translation in a bacterial lysate supplemented with the eukaryotic chaperonin TRiC. Biol Chem 386: 753-757.
28. Sun L, Finnegan CM, Kish-Catalone T, Blumenthal R, Garzino-Demo P, Maggiore GMLT, Berrone S, Kleinman C, Wu Z, Abdelwahab S, Lu W, Garzino-Demo A. 2005. Human ß-defensins suppress human immunodeficiency virus infection: Potential role in mucosal protection. J Virol 79: 14318-14329.
29. Tang Y-Q, Selsted ME. 1993. Characterization of the disulfide motif in BNBD-12, an antimicrobial β-defensin peptide from bovine neutrophils. J Biol Chem 268: 6649-6653.
30. Taylor K, Barran PE, Dorin JR. 2007. Structure-activity relationships in b-defensin peptides. Pep Sci 90(1): 1-7.
31. Yang D, Biragyn A, Kwak LW, Oppenheim JJ. 2002. Mammalian defensins in immunity: More than just microbicidal. Trends Immunol. 23: 291-296.
32. Yeaman MR, Yount NY. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55: 27-55.
33. Yee A, Chang X, Pineda-Lucena A, Wu B, Semesi A, Le B, Ramelot T, Bhattacharyya GMLS, Gutierrez P, Denisov A. and others 2001. An NMR approach to structural proteomics. PNAS 99(4): 1825-1830.
34. Zaiou M. 2007. Multifunctional antimicrobial peptides: Therapeutic targets in several human diseases. J Mol Med 85: 317-329.
35. Zhou C, Qi X, Li P, Chen W, Mouad L, Chang M, Leong S, Chan-Park M. 2010. High potency and broad-spectrum antimicrobial peptides synthesized via ring-opening polymerization of alpha-aminoacid-N-carboxyanhydrides. Biomacromolecules 11(1): 60-67.